Share-Based Compensation - Summary of Stock Option Granted (Details) |
9 Months Ended |
|---|---|
|
Sep. 30, 2022
$ / shares
| |
| Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
| Weighted average fair value | $ 2.70 |
| Weighted average exercise price | $ 9.11 |
| Remaining average contractual team (years) | 9 years 4 months 24 days |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|